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SUMMARY 
• Peripheral nerves respond to injury in a unique 
fashion. Changes in the local milieu of the injured nerve 
trunk may determine both the likelihoods of regeneration 
and the production of neuropathic pain. For example, 
changes in local blood flow within this microenvironment 
may reflect several interesting features of the repair process. 
Crushed and sectioned nerves develop hyperemia, or rises 
in local blood flow rather than ischemia, and these rises 
appear to be mediated by one of several mechanisms. 
Firstly, vasa nervorum, the blood vessels that supply nerve 
trunks, are innervated by peptidergic fibers that may 
participate in "neurogenic" inflammation, as occurs in 
other innervated tissues. Secondly, following a nerve section 
or crush, early rises in blood flow may be mediated by local 
deposition of calcitonin gene-related peptide and nitric 
oxide from axonal endbulbs. Thirdly, brisk angiogenesis 
accompanies a proliferative phase in the proximal nerve 
stump that accompanies mast cell proliferation and axonal 
sprouting. Axonal sprouting, in turn, may be supported by 
local trophic factors, and the success of subsequent regrowth 
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down the distal nerve stump may be determined by the 
microenvironment it encounters on its road to recovery. 
Better understanding of these and other events in injured 
nerve trunks is needed to help solve the two cardinal 
problems of peripheral nerve injuries: functional disability 
from impaired regeneration and the development of disabling 
neuropathic pain. (Biomed Rev 1997; 8: 37-54) 
INTRODUCTION 
• Peripheral nerve damage arising from trauma or dis 
ease (acquired or inherited neuropathies) is common and dis 
abling. Our understanding of local repair mechanisms of in 
jured peripheral nerves, however, is incomplete. The attempted 
regeneration of fibers occurs within a nerve trunk microen 
vironment milieu replete with inflammatory mediators, 
trophins, microvascular changes and proliferating cellular 
elements. How this milieu develops and influences regenera 
tion is uncertain. This contrasts with the certainty that recov 
ery from human axonal degeneration is slow, often incomplete 
and frequently painful. 
Why is the microenvironment important? The classical 
monograph written in 1949 by William Lyons and Barnes 
Woodhall entitled "Atlas of peripheral nerve injuries" (1) 
catalogued pathological changes of peripheral nerve 
specimens taken by surgeons attempting to repair war wounds 
of American soldiers in World War II. The procedures that 




relieve obvious disability and pain by surgical approaches. The 
micrographs are dramatic, with examples of neuromas (a 
swollen mass of ineffectively regenerating peripheral nerve 
sprouts), neuromas in continuity, stretch and compression 
injuries, inadequate attempts at repair, and other problems. 
There are photomicrographs of poorly regenerated specimens 
taken sometimes months after the injury with axons 
ineffectually attempting to penetrate masses of fibrotic 
tissue. Local microvessels are frequently thrombosed and 
tissue ischemic. A subsequent paper concentrates on these 
devastating microvascular changes (2). 
Several of the themes in the story of peripheral nerve repair 
are beginning to emerge. It is clear that recovery from injury 
and the marshalling of regenerative processes follow an 
interesting and apparently coordinated timetable of actions 
that begin soon after the injury. Although likely to share 
features observed in any form of tissue repair, the peripheral 
nerve trunk recovers from injury in several unique ways. 
Axons must bridge injured gaps, and regrow through previously 
denervated nerve trunks to their targets. To do so, they must 
grow new axonal sprouts, penetrate the injury milieu and find 
their way into and down the distal nerve trunk. At each step of 
this process, the microenvironment must favour successful 
regeneration by delivering or generating trophic signals, by 
supplying metabolic requirements, and by maintaining a distal 
nerve trunk that is suitable to support large numbers of 
regrowing axons. Each of these steps involves, and is reliant 
upon the nerve trunk microcirculation, or vasa nervorum. 
THE MICROCIRCULATION OF PERIPHERAL 
NERVES AND GANGLIA 
• Anatomy of vasa nervorum 
Peripheral nerve trunks have an intrinsic nutritive 
microcirculation, largely capillary, that is supplied by local 
and remote feeding arterioles from an extrinsic epineurial 
plexus (3). Endoneurial capillaries are large, nonfenestrated, 
with a prominent basement membrane, a near complete 
pericyte investment and frequent pinocytotic vesicles. 
Arterioles are often thin walled with a rudimentary internal 
elastic lamina making them sometime difficult to distinguish 
from venules. In the extrinsic epineurial plexus, arterioles 
(and perhaps venules) are innervated by vasoconstrictive 
adrenergic fibers, and vasodilatory peptidergic fibers 
containing substance P (SP) and calcitonin gene-related 
peptide (CGRP) (4-11). Nervi nervorum, or the fibers that 
innervate vasa nervorum, appear to be particularly expressed in 
the epineurium, but not in endoneurial microvessels (12). 
Some noradrenergic perivascular fibers also contain neuro-
peptide Y. Other epineurial perivascular fibers are immuno-
reactive to SP and CGRP or to CGRP alone. Axons immuno- 
reactive to vasoactive intestinal peptide (VIP) innervate 
epineurial microvessels of the facial and vagus, but not sciatic 
nerves (12). An important characteristic of the vascular 
supply of peripheral nerves is their rich anastomotic blood 
supply (13,14). This rich arteriovenous (AV) shunt flow is 
particularly prominent in the epineurial plexus but both the 
epineurial and endoneurial compartments may be thought of 
as a large continuous interconnected vascular bed (3). Since 
the endoneurium contains relatively few arterioles, it is likely 
that nutritive flow in this compartment is regulated by local 
penetrating branches from or distant longitudinal branches 
from the epineurium, where vessel caliber is regulated. 
• Local measurement of blood flow 
Several methods are available for the measurement of local 
blood flow in small tissues like peripheral nerve and ganglia, 
but each offer advantages and disadvantages. Indeed some 
controversy has arisen over these techniques because of 
discrepancies in reports of changes of nerve blood flow in 
experimental diabetes. The topic of nerve blood flow 
measurement has been reviewed in detail elsewhere (15,16). 
Hydrogen clearance polarography measurements employ 
small (3-5 micron tipped) hydrogen sensitive microelectrodes 
that can be inserted within the endoneurium or dorsal root 
ganglia with minimal trauma. The clearance of hydrogen 
administered to saturation through a ventilatory gas mixture in 
paralysed and ventilated animals is measured by the 
microelectrode. Blood flow is calculated from a biexponential 
or monoexponential curve fit. Theoretical aspects of hydrogen 
clearance in general, and its application to nerve in particular, 
have been discussed (16,17). The slow component of 
biexponential curves correlates with endoneurial blood flow 
(EBF), as measured by other techniques, whereas the fast 
component has contributions from the epineural plexus and 
AV shunts. While the hydrogen clearance polarography 
technique is somewhat invasive and requires 30-60 minutes of 
data collection time, it offers quantitative data selective for 
the endoneurial space and permits serial blood flow studies to be 
made in the same preparation, for example, before and after 
pharmacological intervention. The theoretical sphere of 
sensitivity for hydrogen microelectrodes has been reported to 
be approximately 30 microns (18,19). 
The laser doppler flowmetry (LDF) technique measures red 
blood cell (RJBC) flux in the tissue sampled beneath afferent 
and efferent fiberoptic probes. The signal recorded is a 
function of the laser signal to the afferent probe reflected 
from moving RBC, and its magnitude depends on the velocity 
and number of moving RJBC. LDF is simple to apply but there 
are important caveats toward obtaining reproducible signals. 
The recordings, influenced by ambient room light including 
heating lamps, are dependent on probe position, and individual   
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measurements can be quite variable along the length of a 
peripheral nerve because of variations in the anatomy of the 
epineurial vascular plexus. Measurements should be made 
under strict conditions with all light sources turned off and a 
mean RBC flux signal should be calculated from pooled 
multiple individual measurements along the nerve trunk (20). 
Unlike hydrogen clearance polarography, the signal obtained 
with LDF is a relative flow signal. By taking measurements 
over the epineurial surface of the nerve trunk, the signal is 
biased toward measurements of epineurial blood flow, 
despite limited penetration and sampling of the endoneurium. 
The technique provides real time data and does not require 
animal sacrifice. Other measurement techniques employed to 
measure peripheral nerve perfusion include tracer methods 
using radiolabelled microspheres, or labelled iodoantipyrene 
(21). These techniques provide only single measurements. 
AV shunting of microspheres may give inappropriately low 
values of EBF. Video angiology allows direct visualization of 
epineurial vessels and India-ink perfusion is useful in 
outlining microvessels for morphometric studies (9,22). 
• Nerve blood flow 
In resting anaesthetized rats, normal EBF has been measured 
between 15 and 20 ml/lOOg/min, [19.1±0.4; n=161; (23)] 
using hydrogen clearance polarography with the nerve bathed in 
a pool of mineral oil at 37°C. Microvascular resistance is 
calculated as MAP/EBF (6.93±0.18 mmHg. 100g.min.ml-l; 
n=161), where MAP is mean arterial pressure. Selective EBF 
measurements using hydrogen clearance polarography and 
labelled iodoantipyrene uptake have given similar values. 
Blood flow in the epineurial space has been more difficult to 
measure because of the presence of AV shunts. Microsphere 
measurements have suggested that blood flow is higher than 
that of the endoneurium, estimated as 33 ml/lOOg/min (21). 
By weighing contributions of the biexponential hydrogen 
clearance curves, a "composite" blood flow measurement, 
taking into account endoneurial, epineurial, and AV shunt flow 
was estimated as 32.0±1.2 ml/lOOg/min; n=161 a value 
similar to iodoantipyrene results (27±3 ml/lOOg/min; n=14 
(21). 
Under normal physiological conditions, there appears to be 
both tonic adrenergic and peptidergic tone on vasa nervorum, 
and overall changes in nerve blood flow follow those of MAP 
passively, indicating little autoregulation (24,25). EBF 
increases and decreases in a curvilinear fashion with changes in 
mean arterial pressure. EBF appears to be independent of 
CO2, whereas epineurial flow gauged real time by LDF had 
some limited CO2 sensitivity (26). The short term 
administration of an a-adrenergic blocking agent, such as 
phentol-amine, or chronic sympathectomy by guanethidine is 
associated with rises in EBF (8,9). Live video microscopy of 
epineurial vessels exposed to norepinephrine identified an 
interesting segmental pattern of vasoconstriction suggesting 
an uneven distribution of alpha receptors along the vessel, 
perhaps indicating that there are specific zones of receptor 
clustering, where feeding vessels control downstream 
perfusion (9) (Fig. 1). Vasa nervorum are also sensitive to 
vasoconstriction from endothelin-1 (ET-1), a peptide with yet 
greater potency than that of norepinephrine. In experiments 
with topical application of endothelin over epineurial vessels, 
ET-1 induced endoneurial ischemia that resulted in transient 
acute conduction block of myelinated motor fibers (27). In 
diabetics, ET-1 induced endoneurial ischemia caused frank 
nerve infarction (28). 
Administration of specific antagonists of either SP or CGRP, is 
associated with vasoconstriction and a fall in EBF (29). 
Thus, vasa nervorum have alpha receptors that mediate 
vasoconstriction in response to exogenous norepinephrine 
and CGRP receptors, likely type-1 (30), that cause vaso-
dilatation when exposed to exogenous peptide. CGRP is a 
highly potent vasodilator, with actions mediated in part by 
ATP-sensitive K+ channels (following activation of adenyl 
cyclase and generation of local cyclic AMP), but also in part 
related to cyclic GMP and nitric oxide (NO) produced by 
endothelialNO synthase (eNOS) (31-34). While tonic CGRP 
vasodilation may operate through eNOS in some vascular 
beds, it may be that vasa nervorum dilatation by CGRP is NO 
independent, instead acting wholly through ATP-sensitive K+ 
channels. Inhibition of NOS had no influence on resting nerve 
blood flow (35). The role of SP receptors is unclear: CGRP is 
a much more potent and longer acting vasodilator than SP 
(10). Selected prostaglandins have also been demonstrated to 
dilate vasa nervorum: PGE,, PGL, and PGF2 (36). 
• Ganglia blood flow 
Local blood flow in sensory and autonomic ganglia has not 
been measured as frequently as in nerves. Using hydrogen 
clearance microelectrode polarography, L4/5 dorsal root 
ganglia blood flow measured 36.1±2.7 ml/lOOg/min, (n=13), 
or approximately twice the value for nerve (37). Unlike 
peripheral nerves, we did not detect a relationship between 
MAP and ganglion blood flow until MAP fell below 60 mmHg. 
The absence of a relationship indicated that ganglia, unlike 
nerves, possessed some degree of autoregulation. Hypercarbia 
and hypocarbia had no influence on ganglion blood flow. In 
addition, oxygen tension histograms were shifted to 
somewhat lower values than that of nerve. The unique micro-
vascular characteristics of sensory ganglia and relative hy-
poxia may reflect the higher metabolic requirements of 
ganglion neurons, in comparison to the nerve trunk. It may be 
that these higher demands entrain both local rises in blood 
flow and induce autoregulation. Recently, these findings were 
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Figure 1. Segmental vasoconstriction of an epineural microvessel exposed to bathing with norepinephrine. The 
photomicrograph on the left precedes treatment, and that on the right is after norepinephine. Uneven vasoconstriction 
suggested an uneven distribution of a-adrenergic receptors along the vessel. From Ref 9, with permission.
verified using another technique for measuring blood flow, 
uptake of labelled iodoantipyrene (38). 
ARE  INJURED PERIPHERAL  NERVES   
ISCHEMIC? 
• An expected response of the peripheral nerve to 
traumatic injury, as in other tissues, is ischemia. Ischemia 
might arise from local disruption of the epineurial or 
endoneurial circulation with local thrombosis, endothelial 
swelling, granulocyte plugging or actual physical interruption 
of microvessels (2, 39). These events might result in no 
reflow and continuing fiber damage as occurs in prolonged 
nerve ischemia associated with vascular ligation (40). An 
additional problem following trauma might be the develop 
ment of endoneurial edema with microvascular compression. 
In the central nervous system, subarachnoid hemorrhage from 
aneurysmal rupture is also associated with intense cerebral 
vasospasm. In the spinal cord, acute compression injury is 
associated with cord ischemia (41). Some studies of acute 
mechanical injury of peripheral nerve by compression or 
crush postulated that ischemia was also an important mecha 
nism of injury (14, 42, 43). The issue is of obvious impor 
tance, because ischemia might have considerable impact on 
the local regenerative milieu.  
We studied the impact of local nerve crush of the sciatic 
nerves of rats on EBF measured by hydrogen clearance 
polarography directly at the site of injury (44). The crush was 
administered by a hemostatic clamp applied across the nerve 
along a 3 mm segment for up to 3 hours with control rats 
having undergone nerve exposure only. Both precrush and 
postcrush measurements were made. Contrary to expectation, 
nerve crushes of duration 30 seconds, 2 hours or 3 hours were 
not associated with evidence of local ischemia either 
immediately after the clamp was removed or up to 2 hours 
later, when endothelial swelling and granulocyte plugging 
might have been expected to occlude vessels. There was a 
slight trend toward higher blood flow in the crushed nerve in 
comparison to controls after 2 hours. Similarly, oxygen 
tensions within the endoneurial space did not decline. The 
findings suggested that local ischemia was not an expected 
consequence of focal nerve injury, and that other factors must 
compensate for any direct microvessel damage. There might 
be the opening of previously closed vessels, release of local 
vasodilators or compensation for injury by the rich anasto-
motic supply of the nerve trunk. Measurements of local EBF 
made at later time points after injury, 24 and 48 hours (45), 
indicated that flow increased beyond the normal range, a 
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CGRP receptor antagonist, hCGRP (8-37). This was the first 
evidence we encountered that local vasodilators, in particular 
CGRP, may have a significant impact on the microcirculation 
of injured peripheral nerves. The findings also indicated that 
the peripheral nerve trunk compensated for injury related 
microvessel damage by peptidergic vasodilation or hyperemia. 
NEUROGENIC  INFLAMMATION  OF THE PERIPHERAL 
NERVE    TRUNK 
• Work in other tissues has demonstrated that 
peptidergic unmyelinated nerve fibers participte in inflam 
matory processes (46-48). Perivascular peptidergic fibers 
transmit nociceptive information centrally, but also deliver 
peptides locally to the injury site. These local peptides in turn 
augment the inflammatory process as part of the process of 
neurogenic inflammation. SP, the first peptide studied, is a 
local vasodilator, induces plasma extravasation to cause 
edema, and degranulates mast cells. CGRP, a more recently 
recognized peptide, is a more potent vasodilator than SP and 
is coreleased with it. Histamine from mast cells, and perhaps 
other substances, may in turn further depolarize unmyelinated 
axons activating further peptidergic fibers. Neurogenic 
inflammation likely involves the axon reflex whereby fiber 
depolarization spreads in a retrograde fashion to other branches 
of the same parent axon to widen the territory involved (46, 
49). Thus, peptidergic afferents contribute to the Gallenus 
features of inflammation: tumor (swelling, or edema from 
plasma extravasation), rubor and color (redness and heat from 
vasodilation), and dolor (pain from activation of nociceptive 
unmyelinated fibers). 
Immunohistochemical and pharmacological work has 
demonstrated that vasa nervorum, like other tissues, are also 
innervated by peptidergic fibers capable of potentiating an 
inflammatory process (10, 50, 51). That the peripheral nerve 
trunk is self innervated and capable of participating in its own 
inflammatory processes is a novel concept, and is interesting. 
We tested neurogenic inflammatory vasodilation in sciatic 
nerves of rats by acutely depolarizing peptidergic periva-
scular nerve terminals innervating vasa nervorum with 
capsaicin. Capsaicin treatment in long term experiments 
results in a retrograde destruction of SP- and CGRP-con-
taining unmyelinated fibers, but in the short term releases 
these peptides locally into the perivascular space (48). 
Capsaicin evoked a brisk, potent and sustained vasodilatory 
response in the sciatic nerve (Fig. 2, 3). Moreover, this 
response could be blocked by inhibitors of the CGRP 
receptor, the SP receptor, by prior capsaicin desensitization, by 
morphine, antihistamines, and cromolyn sodium, an inhibitor 
of mast cell degranulation (10,50) (Fig. 3). Since the full 
response was so sensitive to a variety of approaches, we 
postulated that its full expression involved the participation of 
CGRP particularly, but also SP, mast cells, and histamine. The 
sensitivity to morphine suggested that local opioid receptors, 
perhaps on peptidergic fibers might inhibit peptide releases. 
Opioids also inhibit activation of smooth muscle adenyl 
cyclase (52-54), an important direct action that may dampen 
neurogenic inflammation. Prior section of the nerve proxi-
mally had no influence on capsaicin hyperemia and indicated 
that its action was truly local. In contrast, section of the nerve 2 
weeks before the experiment eliminated the capsaicin 
hyperemic response (Zochodne and Ho, unpublished data). 
By two weeks, section of the proximal nerve trunk resulted in 
axonal degeneration of the nerve terminals innervating the 
vasa nervorum, eliminating the capsaicin response. In 
contrast, section of the nerve trunk at the time of the 
experiment had no immediate influence on the capsaicin 
response because the terminals had not degenerated yet. The 
findings suggest that vasa nervorum are indeed innervated by 
the same parent nerve trunk they supply. There is similar 
evidence that adrenergic fibers innervating vasa nervorum 
arise from the parent nerve trunk (12, 55). Stimulation of the 
nerve trunk or its dorsal root supply appears to preferentially 
activate peptidergic perivascular fibers, resulting in 
vasodilation of vasa nervorum that depends on the 
stimulation frequency and is blocked by a CGRP receptor 
antagonist (11, 56). 
RESPONSE TO  INJURY:  EARLY STAGES IN THE PROXIMAL 
STUMP 
• Following peripheral nerve crush or transection, 
there are interesting and distinct changes that occur in both the 
distal denervated stump and the proximal stump. In the distal 
stump, local events prepare the environment for the entry of 
newly sprouted axons, including the formation of Schwann- 
basement membrane cell tubes or bands of Bungner, 
elaboration of growth factors such as nerve growth factor 
(NGF) and brain derived neurotrophic factor (BDNF) by 
Schwann cells, and changes in the characteristics of the basal 
lamina. These events occur in the context of breakdown of 
myelin and axons from the previously sectioned nerves, 
disruption of the blood-nerve barrier and the invasion of 
macrophages. These events are of obvious importance, but 
have been reviewed in detail by others and will not be 
discussed further here (57, 58). . 
Relatively less attention has been paid to local events in the 
proximal stump of injured nerves and their relationship to 
regeneration. The classical monograph by Cajal (59) on 
degeneration and regeneration in the nervous system and 
detailed ultrastructural studies by Morris et al (60-63) both 
outlined important features of proximal nerve stumps where 
early regenerative events begin. Axonal endbulbs described 
by these authors resulted from the enlargement of transected 
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Duration of treatment 
Figure 2. Sciatic nerve endoneurial blood flow (EBF) in rats treated with epineurial capsaicinfor varying times. EBF was 
significantly increased by capsaicin, accounted for by local release of SP and CGRP from perivascular fibers innervating 
epineural vessels. From Ref 10, with permission. 
  
axons with accumulation of axoplasmic material. While 
axonal endbulbs have generally been considered as interesting 
pathological phenomena, we have suggested that they represent 
an important local repository of active molecules including 
enzymes and peptides. One such example is CGRP that is 
deposited in proximal nerve stumps of transected nerves 
within 48 hours of transection (23). Dramatic evidence of 
CGRP accumulation in distended axonal endbulbs was 
demonstrated by immunohistochemical labelling of proximal 
stumps of transected sciatic nerves in rats. In longitudinal 
sections of the stumps, CGRP immunoreactivity colocalized 
with neurofilament accumulation in the distal ends of 
individual axons (64). CGRP accumulation peaked by 48 
hours then declined by 7 days. While CGRP acts as a 
neurotransmitter, it is also a very potent vasodilator. Its local 
accumulation in proximal nerve stumps paralleled rises in 
local blood flow in turn reversed by a specific CGRP receptor 
antagonist, hCGRP (8-37). Later, when CGRP accumulation in 
endbulbs was no longer demonstrable, hyperemia was no 
longer reversed by the blocking peptide. These findings 
suggested several interesting possibilities. Firstly, they 
demonstrated possible physiological relevance of axonal 
endbulbs. At early time points after axonal transection, these 
endbulbs must allow some egress of CGRP to dilate local 
vessels. In further work, it was demonstrated that peptide 
accumulation, as demonstrated with CGRP, also occurred 
with SP, NPY and galanin (Zochodne and Cheng, unpublished 
data). Interruption of axoplasmic transport, by a second, more 
proximal axonal transection, completely eliminated peptide 
accumulation (64, 65). We have termed this pattern of early 
peptide accumulation at the ends of transected axons and in the 
extracellular space peptide dumping. Unlike other tissues, the 
nerve trunk may actually be able to participate in its own repair 
in a very interesting way: disrupted local axons may add neuro-
peptides, beyond those released by their own perivascular 
afferents, into the injury milieu, and continue to deposit them 
by local axoplasmic transport. Some anterogradely transported 
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axonal endbulbs without reaching the extracellular space (60). 
Similarly, the function of extracellular dumped peptides is 
unclear, besides the obvious microvascular vasodilator actions 
of SP and CGRP, SP being also a chemoattractant (47), 
CGRP may be a mitogen for Schwann cells and other cellular 
elements, acting through adenyl cyclase and cAMP (66, 67). 
Both peptides degranulate mast cells (47). SP and histamine 
from mast cells both cause plasma extravasation, a potentially 
important route for ingress of trophins from plasma to the 
regenerative milieu. Galanin, in contrast, has been considered 
to have analgesic actions (68). While dumping of peptides 
appears to occur at the injury milieu, parallel alterations in 
peptide expression occur in perikarya of motor and sensory 
axons. CGRP expression, for example, rises in motor neurons 
but declines in sensory perikarya (69-74). 
It is conceivable that dumping of peptide neurotransmitters 
and perhaps selected enzymes may be an early phenomenon of 
other types of axonal interruption such as that following 
central nervous system white matter injury. Two isoforms of 
the NOS, the neuronal (nNOS), and eNOS, also appear to be 
transported and deposited in proximal nerve stumps (35, 64). 
Like CGRP, they can be colocalized with neurofilament in 
axonal endbulbs of the tips of the proximal stumps, and their 
delivery to these stumps is interrupted by a second more 
proximal transection. Moreover, broad spectrum 
pharmacological inhibition of NOS, like the CGRP antagonist, 
reversed hyperemia in inj ured proximal stumps. This evidence 
suggests that NO is locally generated by accumulated NOS in 
axonal endbulbs, and is released into the injury milieu where 
it dilates local microvessels. The potential roles of NO in the 
injury milieu will be considered further below. 
The next major phase of peripheral nerve repair is 
recruitment of blood-borne inflammatory cells, mainly 
macrophages (75). Macrophages deliver a variety of important 
trophins to the regenerative milieu, including basic fibroblast 
growth factor (bFGF), granulocyte-macrophage colony 
stimulating factor (GM-CSF), transforming growth factor-a 
(TGF-a), insulin-like growth factor-I (IGF-I), platelet-derived 
growth factor (PDGF), vascular endothelial growth factor 
(VEGF), interleukin-8, and others (76). Macrophages release 
bFGF from bound heparin through release of proteases (76), 
and stimulate the production of NGF in denervated Schwann 
cells through the action of interleukin-1 (47, 77). They may 
also synthesize NO through inducible NOS (iNOS). In 
neuromas, there are prominent and persistent infiltrations of 
macrophages that could have direct actions on denuded axonal 
membranes (78). Suppression of macrophage function delays 
regeneration (79). 
Based on immunohistochemical criteria, we have considered 
local proliferation the third phase of the proximal stump 
response, following peptide dumping and macrophage 
invasion. Angiogenesis and further vasodilation from 
histamine liberated by mast cells might sustain hyperemia in 
injured nerve proximal stumps after CGRP levels decline. 
Coordinated proliferative events in experimental nerve injuries 
appear after 3-4 days in injured nerve and involve endothelial 
cells, mast cells, axonal sprouts, Schwann cells, fibroblasts, 
and perhaps perineurial cells (22, 60-63, 80-83). Outgrowth 
from the proximal stump allows reconstitution of the nerve 
trunk (84,85). Some of these events are illustrated on Fig. 4. 
Mast cells are likely to be important elements in the repair and 
inflammatory response of peripheral nerves after injury. 
Rises in mast cell numbers from local proliferation (rather 
than recruitment) have been demonstrated in several animal 
models of peripheral nerve damage and as well in human 
neuropathies and neuromas (83, 86-90). Local degranulation   
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Figure 3. Examples of hydrogen microelectrode 
clearance curves indicating changes in slope with 
various interventions applied topically over the epi-
neurial vascular plexus. Actual blood flow values are 
calculated by curve fitting as described in the text. Note 
the faster washout (and flow) associated with acute SP 
and CGRP release from perivascular fibers exposed to 
capsaicin. This is blocked by a CGRP receptor 
antagonist hCGRP (8-37) on the bottom curve. The 
second from the bottom curve is the influence of the 
CGRP antagonist alone, compared to the control (top) 
curve. The curve flattening indicates vasoconstriction, 
implying that CGRP normally tonically dilates vasa 




and release of histamine may be important in opening the 
blood-nerve barrier after injury (87). This in turn may allow 
endoneurial constituents to be influenced by blood-borne 
trophins and other agents during degeneration, and 
regeneration (91). Mast cells also contain a variety of other 
important constituents including growth factors (see below), 
proteolytic enzymes, tumor necrosis factor-a (TNF-a), 
interleukins, and other cytokines (92). Close apposition 
between some mast cells and macrophages and other cell 
types may represent a unique signalling pathway, important in 
the injury environment (reviewed in 92). 
The neurotrophins (NGF, BDNF, NT-3, NT-4/5 and NT-6) 
have been examined by several laboratories. Although NGF 
for example, may not directly influence regenerative fiber 
sprouting, it does promote collateral sprouting, and 
influences the architecture of the regenerating nerve trunk, 
including its neovasculature (93-96). There may be important 
but subtle changes in the peptide characteristics of sprouting 
axons (a different matter than peptide dumping described 
above) that are influenced by neurotrophins and other growth 
factors. For example rat sciatic neuroma axon sprouts express 
CGRP, SP, and NPY (97-99), and a one year old mechano-
sensitive human neuroma studied in our lab (90) had enhanced 
expression of CGRP and SP. In turn, CGRP expression within 
motor sprouts may regulate neuromuscular junction inner-
vation (100-102). Autocrine Schwann cell proliferative and 
migratory signals involve self-expression of NGF and its low-
affinity receptor (103). Mast cells also have the capability of 
secreting NGF (104), and in this context important 
interactions between NGF, CGRP and SP in conditions of 
inflammation take place (105). Interleukin-1 for example, 
regulates NGF synthesis in non-neuronal cells of the sciatic 
nerve (106). BDNF supports motor neurons and rises, along 
with NT-4, in denervated distal sciatic nerve stumps (107). 
There are several non-neurotrophin trophic molecules that 
may participate in the proliferative phase of peripheral nerve 
repair. They include acid FGF (aFGF), bFGF, VEGF, IGFs, 
ciliary neurotrophic factor (CNTF), epidermal growth factor 
(EGF), PDGF, TGF, TNF-a, and presumably several others. 
Many of these factors have been demonstrated to promote 
cutaneous healing and angiogenesis (108-112), and it is very 
likely that they would also support peripheral nerves (113). 
  
 
Figure 4. Photomicrograph from the proximal stump of a rat sciatic nerve transected 14 days earlier. Note the large 
numbers of regenerative units containing myelinated axonal sprouts (r). These sprouts splay apart layers of the previous 
perineurium. Multiple small vessels, several likely newly formed (v) are also observed. Bar, 40 jj,m. 
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Among them, direct evidence of a benefit on nerve 
regeneration has been demonstrated with bFGF (114), aFGF 
(115, 116), IGF-II and insulin (117), and CNTF (118,119). In 
distal denervated nerve stumps, Schwann cells elaborate IGF-I 
and IGF-II (120), TGF-PI (121), and EOF receptors (122). 
Some of these factors may act as autocrine Schwann cell 
mitogens, chemoattractants for macrophages, or modulators 
of cell adhesion molecules (121). EGF receptor rises to 
particularly high levels at the injury site itself, whereas TGF-J31 
appears to be transported distally from axotomized sensory 
neurons (112). Ischemia may also influence their activity 
since peripheral nerves with ischemic axonal degeneration 
regenerate more slowly (123, 124). Some of the non-neuro-
trophin growth factors may benefit nerve regeneration by 
supporting angiogenesis. This possibility has received little 
attention. Among the known potent angiogenic factors, those 
that might act on peripheral nerve in this fashion are bFGF 
(108), TGF-PI (110), VEGF (125), and PDGF (108). 
The next challenge to the peripheral nerve repair process is 
regrowth through the distal nerve stump. Peripheral nerve 
surgeons have realized that reconnection of severed nerve 
trunks is best carried out earlier rather than later, because 
axonal regrowth through long term denervated nerve trunks 
becomes limited. Part of this change in the microenvironment 
for regeneration may be the loss of Schwann cell basement 
membrane columns (bands of Bungner), loss or atrophy of 
Schwann cells themselves, loss of continuous basement 
membrane scaffolding, collagen remodeling and deposition, or 
loss of integrin-pl (126-129). Another possibility is that long 
term denervated trunks become ischemic and unable to 
support the metabolic demands of nerve sprouts (130). 
In summary, four main themes (Fig. 5) appear to be woven into 
the peripheral nerve repair process: (i) reactive hyperemia and 
peptide dumping, (ii) a chemotactic and recruitment phase; 
(Hi) a proliferative phase, and (iv) a reinnervation phase 
requiring regrowth through the distal nerve stump. Later events 
in the injury milieu likely depend on whether there is 
successful regeneration to a distal nerve trunk, or target, 
resulting in reconstitution of the previous appropriate structure 
of the nerve. If this does not occur, local expansion at and 
beyond the site of transection results in the formation of a 
neuroma. What finally arrests neuroma growth is unknown, but 
it could occur because of ischemia from local fibrosis and vessel 
entrapment. 
THE  ROLE  OF  NITRIC  OXIDE 
• One of the important players in the inflammatory 
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be NO and the respective NOS mentioned above (131-133). 
NO might have several potential actions within peripheral 
nerves. It may act as the final pathway for vasodilation by 
CGRP, SP and other locally expressed peptides. nNOS could 
be deposited by sectioned axons to within the injury zone, 
because increased expression in dorsal root ganglion cells 
and anterior horn cells following axotomy has been 
recognized (134, 135). Finally, macrophage recruitment 
might bring with it high levels of iNOS (136) whereas 
inflammatory conditions might result in the expression of iNOS 
in Schwann cells (137, 138). 
We examined the proximal nerve stumps of transected rat 
sciatic nerves for evidence of NO activity and synthesis (35, 
64). Several interesting and unexpected observations were 
made. Local changes in blood flow provided an index of NO 
presence, otherwise very difficult to detect in small nerve 
trunks. Injury-related hyperemia, or rises in nerve blood flow, 
noted to be CGRP-dependent as described above, were also 
highly sensitive to the broad spectrum NOS inhibitors L-
NAME and L-NNA. The NOS inhibitors reversed hyperemia at 
early time points, as observed with the CGRP antagonist, but also 
at later time points when CGRP played no apparent role (see 
above). The findings provided a signature of NO presence. 
Immunohistochemical studies demonstrated that there was 
prominent staining of eNOS, and to a lesser extent of nNOS 
within axonal endbulbs. At later time points, some 
macrophages appeared to express iNOS, although expression 
was infrequent. An assay of NOS activity, using labelled 
arginine to citrulline conversion, identified rises in NO 
generation at later times. Levy in our laboratory (139) also 
observed a very similar pattern of change proximal to sutures 
placed around the sciatic nerve in the chronic constriction 
model, originally developed by Bennett and Xie (140), of 
sciatic neuropathic pain. Proximal to the sutures, NO-related 
hyperemia was identified by 48 hours associated with eNOS 
and some nNOS immunoreactivity. Distal to the sutures, 
where axonal degeneration develops in this model, there was 
both pharmacological and immunohistochemical evidence of 
increased iNOS activity. 
What actions might NO exert within both of these types of 
nerve injury? NO might enhance ectopic activity that 
contributes to the sensations of neuropathic pain. NOS 
inhibitors have systemic and local (near nerve) analgesic 
actions (141), and painful paravascular injections of brady-
kinin or hyperosmolar solutions in humans require activation of 
NOS (142). Another possibility is that NO-mediated 
vasodilation of local blood vessels is required to support the 
metabolic requirements of newly sprouting axons. Finally, 
NO might be detrimental to the regenerative milieu because of 
its conversion to the peroxynitrite, a product with known 
cytoxic properties that induces growth cone collapse (143, 
144). We administered L-NAME to mice for 10 days after 
having undergone transection of the sciatic nerve (145). 
Controls received the inactive enantiomer, D-NAME. 
Regeneration was assessed by the recovery of the compound 
muscle action potential, or M potential of sciatic-tibial innervated 
distal foot muscles and by the numbers and caliber of 
myelinated fibers at a fixed distance beyond the transection 
site by 10 weeks. Our working hypothesis was that NOS ; 
inhibition might impede regeneration by reversing injury- ' 
related rises in local nerve blood flow. Contrary to expectation, 
however, initial investigation suggested that NOS inhibition was 
associated with earlier and more complete recovery of the M 
potential and evidence of more mature myelinated fiber 
regeneration by 10 weeks. While this work requires 
confirmation, it may be that excessive local liberation of NO, 
perhaps in zones where NOS is concentrated, impairs 
regeneration by damaging sprouts or regenerating fibers. 
Further study of the possible actions of NO and NOS in the 
injury milieu, and their interaction with cytokines and other 
inflammatory actors will be of considerable interest. 
NEUROPATHIC   PAIN: POSSIBLE   MECHANISMS 
• While the impact of local events in the injury milieu 
of proximal nerve stumps on regenerative success is still 
unclear, local events might also generate neuropathic pain. 
Pain is a common problem among patients with traumatic 
nerve injury or neuropathies such as that due to diabetes. It 
likely develops because of plastic changes at several 
anatomical levels of the neuraxis. From the previous works, it 
is clear that injured peripheral nerves, particularly those that 
form neuromas, are capable of directing ectopic impulses 
centrally, where they may be perceived as pain (146-150). 
Ectopic activity also arises from dorsal root ganglia central to 
the injury site (151), and there is dorsal horn physiological 
and anatomical remodeling (152-154). Local ectopic dis 
charge generation may be facilitated by the accumulation of 
Na+ channels, observed both in experimental and human 
neuromas (155, 156). The possible local roles of NO, CGRP, 
SP, and mast cell constituents on ectopic discharge firing 
within the injury milieu are unclear. We reported evidence of 
sprouting of CGRP and SP fibers in a mechanosenstive human 
sural neuroma (90). No evidence of adrenergic sprouting, to 
support the concept of local sympathetic activation was 
encountered. In a further report of two patients with local 
median nerve lesions, pain accompanied evidence of 
activation of peptidergic but not adrenergic fibers in the 
injured nerve territory, resulting in highly localized redness 
(from vasodilation) and edema (from plasma extravasation), 
findings traditionally ascribed to reflex sympathetic dys 
trophy (157). The role of sympathetic activation of neuro 
pathic pain, however, cannot be discarded since adrenergic 
agonists enhance neuroma discharges. Following nerve   
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CONCLUSION 
• There are many facets of the microenvironment of 
injured and regenerating peripheral nerves that we do not 
completely understand yet. We do not know, for example, 
how important local microvascular responses and subsequent 
angiogenesis are to the success of fiber regrowth. The possi 
bilities, however, of a major role for peptides, such as SP and 
CGRP, NO, and local opioid receptors offer several exciting 
avenues to explore. It may be that their actions on nerve 
microvessels from injured nerves simply reflect a much 
broader scope of action in the repair process of nerve. 
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